
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+13
ASC Therapeutics focuses on the development of curative therapies for rare diseases. Our gene, CRISPR and cell therapies were developed at Applied StemCell, a life sciences company for over 12 years, including proprietary gene editing technologies. Our development pipeline includes several preclinical stage projects focusing on monogenic blood disorders that exhibit a high genetic penetrance and conditions requiring immunomodulatory interventions. Contact us for partnership opportunities. #therapeutics #CRISPR #celltherapy #genetherapy #blooddisorders #hemophilia www.asctherapeutics.com
Clinical,biologics,aav,cell therapy,gene therapy,biotech,therapeutic,genome editing,blood disease,genetic disease,crispr,phase i study,gene replacement,stem cells,biotech venture,start up,phase ii,and drug development
Asc therapeutics operates in the Biotechnology industry.
Asc therapeutics's revenue is 11m - 100m
Asc therapeutics has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.